Q4 Diagnostics Revenues Remain Strong Despite Fall in COVID-19 Testing
...
Already a member? Log in here
Resurgence of COVID-19 Cases Threatens to Derail Recovery of Core Business
...
Already a member? Log in here
Q2 Revenues Slide but By Less than Wall Street Expected
...
Already a member? Log in here
DX Earnings Report: Lab Market Consolidates but Survivors Stay Strong
PAMA and private payor rate cuts and increased market competitiveness are fueling consolidation and driving smaller, independent labs (other than specialty labs) into near extinction. But the big, established companies continue to chug along, not only via acquisition revenues but
Already a member? Log in here
DX Earnings Report: Markets Soften, Payors Harden but Growth Continues
From - Laboratory Industry Report
Lab business is getting tougher. While PAMA cuts are hurting Medicare revenues, pressure from private payors may…
Already a member? Log in here